Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.6B | 6.2B | 6.3B | 5.7B |
Cost of revenue | — | — | — | — |
Gross profit | 7.6B | 6.2B | 6.3B | 5.7B |
Operating expense | ||||
Research & development | 196.9M | 146.4M | 127.1M | 97.4M |
Selling general and admin | 7.5B | 4.6B | 4.5B | 4.0B |
Other operating expenses | 143.0M | 175.5M | 94.4M | 143.5M |
Operating income | 7.6B | -11.0M | 254.2M | 171.5M |
Non operating interest income | ||||
Income | 69.8M | 54.1M | 54.1M | 85.2M |
Expense | 25.0M | 30.5M | 21.0M | 578.3M |
Other income expense | — | — | — | — |
Pretax income | 54.0M | 6.4M | 253.5M | 244.8M |
Tax provision | -294.2K | -32.7M | — | — |
Net income | 54.3M | 39.1M | -59.5M | 244.8M |
Basic EPS | 3.0 | — | — | — |
Diluted EPS | 3.0 | — | — | — |
Basic average shares | — | — | — | — |
Diluted average shares | 27.1M | — | — | — |
EBITDA | 7.6B | 287.3M | 545.1M | 1.1B |
Net income from continuing op. | 54.3M | 39.1M | -59.5M | 244.8M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |